BACKGROUND: Studies investigating structural brain abnormalities in depression have typically employed a categorical rather than dimensional approach to depression [i.e., comparing subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM)-defined major depressive disorder (MDD) v. healthy controls]. The National Institute of Mental Health, through their Research Domain Criteria initiative, has encouraged a dimensional approach to the study of psychopathology as opposed to an over-reliance on categorical (e.g., DSM-based) diagnostic approaches. Moreover, subthreshold levels of depressive symptoms (i.e., severity levels below DSM criteria) have been found to be associated with a range of negative outcomes, yet have been relatively neglected in neuroimaging research. METHOD: To examine the extent to which depressive symptoms--even at subclinical levels--are linearly related to gray matter volume reductions in theoretically important brain regions, we employed whole-brain voxel-based morphometry in a sample of 54 participants. RESULTS: The severity of mild depressive symptoms, even in a subclinical population, was associated with reduced gray matter volume in the orbitofrontal cortex, anterior cingulate, thalamus, superior temporal gyrus/temporal pole and superior frontal gyrus. A conjunction analysis revealed concordance across two separate measures of depression. CONCLUSIONS: Reduced gray matter volume in theoretically important brain regions can be observed even in a sample that does not meet DSM criteria for MDD, but who nevertheless report relatively elevated levels of depressive symptoms. Overall, these findings highlight the need for additional research using dimensional conceptual and analytic approaches, as well as further investigation of subclinical populations.
BACKGROUND: Studies investigating structural brain abnormalities in depression have typically employed a categorical rather than dimensional approach to depression [i.e., comparing subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM)-defined major depressive disorder (MDD) v. healthy controls]. The National Institute of Mental Health, through their Research Domain Criteria initiative, has encouraged a dimensional approach to the study of psychopathology as opposed to an over-reliance on categorical (e.g., DSM-based) diagnostic approaches. Moreover, subthreshold levels of depressive symptoms (i.e., severity levels below DSM criteria) have been found to be associated with a range of negative outcomes, yet have been relatively neglected in neuroimaging research. METHOD: To examine the extent to which depressive symptoms--even at subclinical levels--are linearly related to gray matter volume reductions in theoretically important brain regions, we employed whole-brain voxel-based morphometry in a sample of 54 participants. RESULTS: The severity of mild depressive symptoms, even in a subclinical population, was associated with reduced gray matter volume in the orbitofrontal cortex, anterior cingulate, thalamus, superior temporal gyrus/temporal pole and superior frontal gyrus. A conjunction analysis revealed concordance across two separate measures of depression. CONCLUSIONS: Reduced gray matter volume in theoretically important brain regions can be observed even in a sample that does not meet DSM criteria for MDD, but who nevertheless report relatively elevated levels of depressive symptoms. Overall, these findings highlight the need for additional research using dimensional conceptual and analytic approaches, as well as further investigation of subclinical populations.
Authors: Ming-Ying Du; Qi-Zhu Wu; Qiang Yue; Jun Li; Yi Liao; Wei-Hong Kuang; Xiao-Qi Huang; Raymond C K Chan; Andrea Mechelli; Qi-Yong Gong Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2011-10-07 Impact factor: 5.067
Authors: Diane L Santesso; Ryan Bogdan; Jeffrey L Birk; Elena L Goetz; Avram J Holmes; Diego A Pizzagalli Journal: Soc Cogn Affect Neurosci Date: 2011-09-14 Impact factor: 3.436
Authors: Michael T Treadway; Merida M Grant; Zhaohua Ding; Steven D Hollon; John C Gore; Richard C Shelton Journal: PLoS One Date: 2009-03-26 Impact factor: 3.240
Authors: Molly E McLaren; Sarah M Szymkowicz; Andrew O'Shea; Adam J Woods; Stephen D Anton; Vonetta M Dotson Journal: Psychiatry Res Neuroimaging Date: 2016-12-16 Impact factor: 2.376
Authors: Casey Paquola; Maxwell R Bennett; Sean N Hatton; Daniel F Hermens; Jim Lagopoulos Journal: Hum Brain Mapp Date: 2017-03-03 Impact factor: 5.038
Authors: Jeroen Blommaert; Gwen Schroyen; Mathieu Vandenbulcke; Ahmed Radwan; Ann Smeets; Ron Peeters; Charlotte Sleurs; Patrick Neven; Hans Wildiers; Frédéric Amant; Stefan Sunaert; Sabine Deprez Journal: Hum Brain Mapp Date: 2019-08-21 Impact factor: 5.038
Authors: Sarah M Szymkowicz; Molly E McLaren; Joshua W Kirton; Andrew O'Shea; Adam J Woods; Todd M Manini; Stephen D Anton; Vonetta M Dotson Journal: Int J Geriatr Psychiatry Date: 2015-07-23 Impact factor: 3.485
Authors: Marc S Lener; Prantik Kundu; Edmund Wong; Kaitlin E Dewilde; Cheuk Y Tang; Priti Balchandani; James W Murrough Journal: J Affect Disord Date: 2015-10-30 Impact factor: 4.839
Authors: Sarah M Szymkowicz; Adam J Woods; Vonetta M Dotson; Eric C Porges; Nicole R Nissim; Andrew O'Shea; Ronald A Cohen; Natalie C Ebner Journal: Aging Ment Health Date: 2018-01-30 Impact factor: 3.658
Authors: Christian A Webb; Elizabeth A Olson; William D S Killgore; Diego A Pizzagalli; Scott L Rauch; Isabelle M Rosso Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-08-26
Authors: Vivian Schultz; Robert A Stern; Yorghos Tripodis; Julie Stamm; Pawel Wrobel; Christian Lepage; Isabelle Weir; Jeffrey P Guenette; Alicia Chua; Michael L Alosco; Christine M Baugh; Nathan G Fritts; Brett M Martin; Christine E Chaisson; Michael J Coleman; Alexander P Lin; Ofer Pasternak; Martha E Shenton; Inga K Koerte Journal: J Neurotrauma Date: 2017-11-17 Impact factor: 5.269
Authors: Frederike Stein; Tina Meller; Katharina Brosch; Simon Schmitt; Kai Ringwald; Julia Katharina Pfarr; Susanne Meinert; Katharina Thiel; Hannah Lemke; Lena Waltemate; Dominik Grotegerd; Nils Opel; Andreas Jansen; Igor Nenadić; Udo Dannlowski; Axel Krug; Tilo Kircher Journal: Schizophr Bull Date: 2021-10-21 Impact factor: 9.306